home
•
contacts
•
sitemap
•
japan
•
search
About
Company Overview
History
Management Team
Board of Directors
Locations
Careers
Pipeline
BTG Pipeline
Partnered Programmes
Marketed Products
Business Development
Our Focus
Partnering Opportunities
Contacts
Investors
Share Price Data
Stock Exchange Announcements
Press Releases
Financial Reports & Accounts
Financial Results
Presentations
BTG Share Dealing Facility
Email Alerts
Financial Calendar
Corporate Governance
Corporate Social Responsibility
Investor Contacts
News
Press Releases
Stock Exchange Announcements
Events
Publications
Email Alerts
Media Contact
Pipeline
BTG Pipeline
Varisolve
®
BGC20-0582
BGC20-0166
BGC20-1259
BGC20-1531
BGC20-0134
Partnered Programmes
Campath
®
CB7630 (abiraterone)
TRX4
Misopess™
ABIO-0801
Juvidex™
Modafinil Combination
ONX 0801
β-Amyloid Inhibitors
Marketed Products
Pipeline
>
Partnered Programmes
>
β-Amyloid Inhibitors
β-Amyloid Inhibitors
Product
β-Amyloid Inhibitors
Licensee
Senexis
Indication
Alzheimer's disease
Phase
Lead optimisation
Description
Novel inhibitors of β-amyloid toxicity.
Return to Pipeline
© BTG International Ltd 2008 •
Legal Notice
•
Accessibility
Product